University of Minnesota. Driven to Discover.
Peramivir, made by BioCryst, is intended to be given to influenza patients in a single intravenous dose.
Almost 70% of H3N2 strains are mismatched with the vaccine, and 4 more kids have died.
An H3N2 mismatch may portend a tough season and raises vaccine questions.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.